Teva launches generic Restasis in Canada

May 18, 2018

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, announced the launch of a twice-daily eye drop solution — the first generic version of Allergan’s Restasis in Canada.

Teva-Cyclosporine is available immediately to pharmacies across Canada.

In the U.S., Allergan is still locked in patent battles with Mylan and Teva over Restasis, but Teva's Canada launch could put pressure on the U.S. court system and the FDA to push a generic version of the drug.

Read the press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments